Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They only tapped into $4M of the lind deal. Don’t listen to that Ham guy, he has no idea what he’s talking about.
My guess is new offering is being bought up by foreign investors since they brought on the new international president.
What’s Aug 16?
Only 264M shares. Joey got his settlement money and went into hiding.
I’m not a financial advisor. I only post publicly disclosed information and links. Do your own research.
$ABAT
https://www.tipranks.com/news/company-announcements/american-battery-executives-opt-for-equity-over-cash
“American Battery Technology Company
recently amended offer letters for three top executives, allowing them to substitute portions of their cash compensation with equity. CEO Ryan Melsert opted to exchange $150,000 of his salary for 75,000 restricted stock units (RSUs) and an equal number of warrants, while Chief Resource Officer Scott Jolcover and Chief Operating Officer Andrés Meza made similar elections for $23,000 and $100,000 of their respective salaries. The equity awards will vest immediately upon the entitlement of the cash amounts they replace, signaling a strong commitment from the leadership to the company's future.”
“Kent said in the video that Know Labs is planning to further pare down the wearable device housing the sensor, though the company noted in Tuesday’s announcement that the sensor itself is the same one it will eventually be submitting to the FDA.”
https://www.fiercebiotech.com/medtech/know-labs-finalizes-noninvasive-glucose-sensor-design-sets-sights-fda-pivotal-trial
“ABTC's plant is truly outstanding. Its ability to extract essential metal content from end-of-life batteries means we can minimize our environmental impact at every turn.”
-Troy Zerbe, Nanotech COO
https://www.thegraphenecouncil.org/blogpost/1501180/498703/Truly-outstanding--Reflections-on-a-key-visit-to-sustainability-partner-American-Battery-Technology-Company
Agreed. Revenue coming in as we speak, unfortunately we need to wait until the next 10Q to see the proof.
Ready for Russell 3000/IWV.
Blackrock bought in too. 800K shares.
Makes zero sense. Assets + contracted grant money is $50MM more than the current market cap.
Shut up
Go listen to the shareholders meeting. He tells you exactly what’s up.
2.7M shares being dumped as fast as they can.
The $25M investor was given access to their shares after hours on the 24Th. They’ve been dumping hard since Wednesday. Look at the volume.
.25c —> 28MM shares. Fully diluted will be around 150MM.
White diamond goons are shorting again.
It’s a good thing. Get on a big boy board and get rid of the penny stock designation. Mainstream media outlets will cover them now. T212/IBKR investors in Europe will be able to buy again. Robinhood users will be able to buy. Institutional investors will be able to buy.
Opens the door to a whole lot of opportunity and big money.
There’s a few pics of the OG pilot/GDC but not much new to see. Parking lot paved.
Yes, trucks delivering batteries. Bunch of pics from a couple weeks ago on stocktwits.
A reverse split isn’t necessarily a bad thing if done for the right reasons. It gets labeled as a negative because a lot of companies will do one to avoid delisting, which is not the case here.
Not really considering they will be a multi billion dollar company.
Float is only 421MM shares. The overall o/s is 690MM but a good chunk is restricted for their employee retention program.
ABML @abt_company
Our little OTC company on a panel with Rio Tinto ( $RIO ), Albemarle ( $ALB ), Deputy Asst Secretary of the US Department of Interior (@ENERGY )…
Presenting Tuesday 20 June at 12:10-12:40 PT - @Fastmarkets
https://www.fastmarkets.com/newgen/lithiumsupply-BRM/agenda
$KNW
“The completion of Gen 1 brings Know Labs closer to achieving its ultimate goal of delivering the world’s first FDA-cleared non-invasive blood glucose monitor for the billions of people living with diabetes…”
Video showing the making of the Gen 1:
“If somebody were to make a noninvasive glucose sensor that was as accurate as in a watch, IT WOULD BE A MIRACLE… that would be a great outcome for the world. IT WOULD ALSO BE A CATASTROPHIC EVENT, if you will, FOR US.
-Kevin Sayer, CEO Dexcom
I’m here and ecstatic! Official validation from the Mayo Clinic… huge deal.
$KNW
“The sensor…the guts of the Bio-RFID…is complete.”
-Ron Erickson, CEO & Founder
“We have in house all of the componentry necessary to build 100 of the gen 1 prototypes.”
-Pete Conley, Chief Financial Officer & Senior Vice President Intellectual Property (IP)
Great call! Super Bullish.
Key takeaways from earnings call:
-159 patents approved and pending
-23 institutional investors
-Actively seeking partnerships
-Enough cash to last through Feb 2024
-Target MARD < 10%
CEO Ron tweet:
Great detailed thread on the recent advances and developments @TheKnowLabs $KNW. @diabetesdaily @diaTribeNews @JDRFResearch #diabetes https://t.co/zZ81SSB0zh
— Ron Erickson (@ronerickson) May 9, 2023
$KNW
New page on the Know Labs website - “Research & Validation”
https://www.knowlabs.co/research-and-validation
Lol let’s hope not.
This is what we’ve been waiting for, guy. The results are enough to satisfy the requirements for fda submission but they’re going to continue to refine to make it more accurate.
$KNW In aggregate MARD of 20.6% (the whole). MARD for
Trial 7 9.5%,
Trial 78 10.9%,
Trial 36 12.44%
Trial 40 12.62%
Trial 71 12.78%
Ah hah. This is how data analysis and algorithm refinement works.
“Study demonstrates the Bio-RFID™ sensor can deliver stable, repeatable results in predicting blood glucose concentrations using the Dexcom G6® as a reference device. “
https://www.knowlabs.co/post/know-labs-study-validates-technical-feasibility-of-novel-sensor-for-non-invasive-glucose-monitoring?mc_cid=8fc09dabc4&mc_eid=c415307cea